Nuzenio

Diagnostics Inc

Diagnostics Inc news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 12 publisher sources 100/100 entity strength

Latest news

Insight Molecular Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Tue, 11 Aug 2026 00:00:00 GMT Co-Diagnostics (NASDAQ: CODX) sees Jane Street disclose 1.7% equity stake - Stock TitanStock Titan · Mon, 10 Aug 2026 20:34:23 GMT Insight Molecular Diagnostics (Nasdaq: IMDX) reports steep revenue drop but bolsters cash - Stock TitanStock Titan · Mon, 10 Aug 2026 20:14:42 GMT IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx - GlobeNewswireGlobeNewswire · Mon, 10 Aug 2026 20:05:00 GMT Applied BioCode Reports Record Financial Results for the First Half of 2026; Revenue Increases 81% Year Over Year, Driven by Strong U.S. Molecular Diagnostics Growth - Business WireBusiness Wire · Mon, 10 Aug 2026 14:00:00 GMT Veracyte: Diagnostics With Favorable Economics (NASDAQ:VCYT) - Seeking AlphaSeeking Alpha · Mon, 10 Aug 2026 13:32:02 GMT Non-Invasive Diagnostics for Fibrotic Diseases Market - Future Market InsightsFuture Market Insights · Mon, 10 Aug 2026 12:30:50 GMT Price to sales forward of Lucid Diagnostics Inc. – NASDAQ:LUCD - TradingViewTradingView · Mon, 10 Aug 2026 05:31:39 GMT

Timeline

Tue, 11 Aug 2026 00:00:00 GMTInsight Molecular Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingView

Mon, 10 Aug 2026 20:34:23 GMTCo-Diagnostics (NASDAQ: CODX) sees Jane Street disclose 1.7% equity stake - Stock Titan

Mon, 10 Aug 2026 20:14:42 GMTInsight Molecular Diagnostics (Nasdaq: IMDX) reports steep revenue drop but bolsters cash - Stock Titan

Mon, 10 Aug 2026 20:05:00 GMTIMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx - GlobeNewswire

Mon, 10 Aug 2026 14:00:00 GMTApplied BioCode Reports Record Financial Results for the First Half of 2026; Revenue Increases 81% Year Over Year, Driven by Strong U.S. Molecular Diagnostics Growth - Business Wire

Mon, 10 Aug 2026 13:32:02 GMTVeracyte: Diagnostics With Favorable Economics (NASDAQ:VCYT) - Seeking Alpha

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Inc11 live mentions Median Diagnostics Inc8 live mentions KRX8 live mentions Diagnostics7 live mentions NASDAQ6 live mentions Insight Molecular Diagnostics5 live mentions TradingView TradingView5 live mentions Price4 live mentions Future Market Insights3 live mentions Yahoo3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Diagnostics Inc.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.